Rosenblum Silverman Sutton S F Inc Illumina, Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

$344 Million
Q1 2025

A detailed history of Rosenblum Silverman Sutton S F Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Rosenblum Silverman Sutton S F Inc holds 8,585 shares of ILMN stock, worth $696,157. This represents 0.2% of its overall portfolio holdings.

Number of Shares

8,585

Previous 14,598 41.19%

Holding current value

$696,157

Previous $1.95 Million 65.08%

% of portfolio

0.2%

Previous 0.51%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$79.34 - $144.22 $477,071 - $867,194	-6,013 Reduced 41.19%	8,585 $681,000
Q4 2024 Feb 12, 2025	SELL	$128.99 - $155.15 $45,146 - $54,302	-350 Reduced 2.34%	14,598 $1.95 Million
Q3 2024 Nov 13, 2024	SELL	$105.28 - $135.9 $82,750 - $106,817	-786 Reduced 5.0%	14,948 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $66,996 - $88,556	-663 Reduced 4.04%	15,734 $1.64 Million
Q1 2024 May 14, 2024	SELL	$127.73 - $147.2 $1.36 Million - $1.57 Million	-10,632 Reduced 39.34%	16,397 $2.25 Million
Q3 2023 Nov 13, 2023	SELL	$128.91 - $192.44 $63,552 - $94,872	-493 Reduced 1.79%	27,029 $3.71 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $118,495 - $150,304	646 Added 2.4%	27,522 $5.16 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $832,931 - $999,732	-4,299 Reduced 13.79%	26,876 $6.25 Million
Q3 2022 Nov 15, 2022	SELL	$177.23 - $227.44 $2.36 Million - $3.03 Million	-13,315 Reduced 29.93%	31,175 $5.95 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $2.05 Million - $2.63 Million	11,545 Added 35.04%	44,490 $5.95 Million
Q2 2022 Aug 10, 2022	BUY	$181.58 - $368.0 $64,097 - $129,904	353 Added 1.08%	32,945 $6.07 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $25,221 - $35,175	-83 Reduced 0.25%	32,592 $11.4 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $427,848 - $519,694	-1,232 Reduced 3.63%	32,675 $12.4 Million
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $197,126 - $255,072	-486 Reduced 1.41%	33,907 $13.8 Million
Q2 2021 Aug 12, 2021	BUY	$372.84 - $481.5 $182,691 - $235,935	490 Added 1.45%	34,393 $16.3 Million
Q1 2021 May 17, 2021	SELL	$361.28 - $504.76 $126,447 - $176,666	-350 Reduced 1.02%	33,903 $13 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $143,423 - $181,770	-490 Reduced 1.41%	34,253 $12.7 Million
Q3 2020 Nov 09, 2020	BUY	$268.51 - $400.74 $3,222 - $4,808	12 Added 0.03%	34,743 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$256.46 - $373.01 $40,520 - $58,935	158 Added 0.46%	34,731 $12.9 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $84,726 - $135,889	-405 Reduced 1.16%	34,573 $9.44 Million
Q4 2019 Jan 24, 2020	SELL	$288.29 - $335.49 $294,344 - $342,535	-1,021 Reduced 2.84%	34,978 $11.6 Million
Q3 2019 Nov 01, 2019	SELL	$266.84 - $378.23 $127,015 - $180,037	-476 Reduced 1.31%	35,999 $11 Million
Q2 2019 Jul 31, 2019	SELL	$300.59 - $368.15 $411,808 - $504,365	-1,370 Reduced 3.62%	36,475 $13.4 Million
Q1 2019 Apr 25, 2019	SELL	$272.57 - $321.18 $626,365 - $738,071	-2,298 Reduced 5.72%	37,845 $11.8 Million
Q4 2018 Feb 06, 2019	SELL	$272.46 - $366.54 $559,905 - $753,239	-2,055 Reduced 4.87%	40,143 $12 Million
Q3 2018 Nov 09, 2018	SELL	$279.04 - $367.06 $470,461 - $618,863	-1,686 Reduced 3.84%	42,198 $15.5 Million
Q2 2018 Aug 13, 2018	SELL	$228.17 - $292.07 $317,840 - $406,853	-1,393 Reduced 3.08%	43,884 $12.3 Million
Q1 2018 May 10, 2018	SELL	$209.54 - $253.91 $826,844 - $1 Million	-3,946 Reduced 8.02%	45,277 $10.7 Million
Q4 2017 Feb 01, 2018	SELL	$202.23 - $230.03 $9,302 - $10,581	-46 Reduced 0.09%	49,223 $10.8 Million
Q3 2017 Oct 27, 2017	BUY	$172.3 - $213.93 $8.49 Million - $10.5 Million	49,269	49,269 $9.81 Million

Others Institutions Holding ILMN

# of Institutions

846

Shares Held

154M

Call Options Held

1.52M

Put Options Held

1.24M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $12.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.

Account

Rosenblum Silverman Sutton S F Inc Illumina, Inc. Transaction History